Cresset Asset Management, LLC Charles River Laboratories International, Inc. Transaction History
Cresset Asset Management, LLC
- $19.6 Billion
- Q2 2025
A detailed history of Cresset Asset Management, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 5,530 shares of CRL stock, worth $995,787. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,530
Previous 5,651
2.14%
Holding current value
$995,787
Previous $850,000
1.29%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CRL
# of Institutions
635Shares Held
52.8MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$1.05 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$916 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$678 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$392 Million0.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$335 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.16B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...